ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Essilor Luxottica (PK)

Essilor Luxottica (PK) (ESLOF)

234.86
-3.04
(-1.28%)
Closed January 05 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
234.86
Bid
230.87
Ask
242.90
Volume
472
234.20 Day's Range 242.90
188.00 52 Week Range 252.02
Market Cap
Previous Close
237.90
Open
241.60
Last Trade
23
@
234.86
Last Trade Time
Financial Volume
$ 112,101
VWAP
237.5012
Average Volume (3m)
1,189
Shares Outstanding
445,231,933
Dividend Yield
2.96%
PE Ratio
45.68
Earnings Per Share (EPS)
5.14
Revenue
25.4B
Net Profit
2.29B

About Essilor Luxottica (PK)

Essilor International is engaged in the manufacture, purchase, sale, and trade in any and all eyewear and optical products. In particular, Co. manufactures, purchases and sells spectacle frames, sunglasses, protective glasses and other protective equipment, eyeglass and contact lenses and any and al... Essilor International is engaged in the manufacture, purchase, sale, and trade in any and all eyewear and optical products. In particular, Co. manufactures, purchases and sells spectacle frames, sunglasses, protective glasses and other protective equipment, eyeglass and contact lenses and any and all instruments and materials for use by members of the optical ophthalmics industry. Co.'s ophthalmic lens industry is organized around four separate businesses: raw materials production, series production of lenses, prescription lenses and distribution (through opticians, optometrists and optical products retailers). Show more

Sector
Ophthalmic Goods
Industry
Ophthalmic Goods
Headquarters
Charenton-le-pont, Val-de-marne, Fra
Founded
1971
Essilor Luxottica (PK) is listed in the Ophthalmic Goods sector of the OTCMarkets with ticker ESLOF. The last closing price for Essilor Luxottica (PK) was $237.90. Over the last year, Essilor Luxottica (PK) shares have traded in a share price range of $ 188.00 to $ 252.02.

Essilor Luxottica (PK) currently has 445,231,933 shares outstanding. The market capitalization of Essilor Luxottica (PK) is $105.92 billion. Essilor Luxottica (PK) has a price to earnings ratio (PE ratio) of 45.68.

ESLOF Latest News

Paul du Saillant and Laurent Vacherot Appointed Chief Operating Officers

Paul du Saillant and Laurent Vacherot Appointed Chief Operating Officers PR Newswire CHARENTON-LE-PONT, France, November 29, 2010 CHARENTON-LE-PONT, France, November 29, 2010 /PRNewswire/ -- To...

Essilor - Third-Quarter 2010 Report

Essilor - Third-Quarter 2010 Report - Nine-Month Revenue up 17.6% - Strong Sales In Emerging Markets and the Equipment division PR Newswire CHARENTON-LE-PONT, France, October 22, 2010...

Essilor to Acquire 50% of Shamir Optical

Essilor to Acquire 50% of Shamir Optical PR Newswire KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, October 15, 2010 KIBBUTZ SHAMIR, Israel and CHARENTON-LE-PONT, France, October 15, 2010...

Essilor - First-Half 2010 Results

Essilor - First-Half 2010 Results PR Newswire CHARENTON-LE-PONT, France, August 27, 2010 CHARENTON-LE-PONT, France, August 27, 2010 /PRNewswire/ -- - A Very Good First Half - Sharp Increase...

Essilor Cancels Four Million Shares

Essilor Cancels Four Million Shares PR Newswire CHARENTON-LE-PONT, France, July 13, 2010 CHARENTON-LE-PONT, France, July 13, 2010 /PRNewswire/ -- On June 28, 2010, Essilor cancelled 4,000,000...

Essilor to Appeal Against the BKA's Decision on Anti-Cartel Rules

Essilor to Appeal Against the BKA's Decision on Anti-Cartel Rules PR Newswire CHARENTON-LE-PONT, France, June 10, 2010 CHARENTON-LE-PONT, France, June 10, 2010 /PRNewswire/ -- Essilor was...

Essilor Sells its Stake in Sperian Protection

Essilor Sells its Stake in Sperian Protection PR Newswire CHARENTON-LE-PONT, France, May 19, 2010 CHARENTON-LE-PONT, France, May 19, 2010 /PRNewswire/ -- Sperian Protection's Board of Directors...

Essilor: 2010 Combined Ordinary and Extraordinary Annual Meeting

Essilor: 2010 Combined Ordinary and Extraordinary Annual Meeting PR Newswire PARIS, May 11, 2010 PARIS, May 11, 2010 /PRNewswire/ -- The Combined Ordinary and Extraordinary Annual Meeting of...

Essilor - 2010 First Quarter Report

Essilor - 2010 First Quarter Report - A Solid First Quarter, With Revenue Up 7.8% PR Newswire CHARENTON-LE-PONT, France, April 23, 2010 CHARENTON-LE-PONT, France, April 23, 2010 /PRNewswire/...

Essilor Acquires Signet Armorlite, Exclusive Manufacturer of KODAK Lenses

Essilor Acquires Signet Armorlite, Exclusive Manufacturer of KODAK Lenses PR Newswire CHARENTON-LE-PONT, France, April 2, 2010 CHARENTON-LE-PONT, France, April 2, 2010 /PRNewswire/ -- Following...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-9.2-3.7695648611244.06247.73234.2640240.05071903CS
4-12.59-5.08789654476247.45250234.2567240.95902927CS
121.880.806936217701232.98252.02227.811189242.17275466CS
2620.469.54291044776214.4252.02200.74881236.31669123CS
5240.1120.59563543194.75252.02188898224.72393856CS
15620.529.57357469441214.34252.02131.481656182.14801272CS
26083.608755.2780042221151.2513252.02101.51791170.67683705CS

ESLOF - Frequently Asked Questions (FAQ)

What is the current Essilor Luxottica (PK) share price?
The current share price of Essilor Luxottica (PK) is $ 234.86
How many Essilor Luxottica (PK) shares are in issue?
Essilor Luxottica (PK) has 445,231,933 shares in issue
What is the market cap of Essilor Luxottica (PK)?
The market capitalisation of Essilor Luxottica (PK) is USD 105.92B
What is the 1 year trading range for Essilor Luxottica (PK) share price?
Essilor Luxottica (PK) has traded in the range of $ 188.00 to $ 252.02 during the past year
What is the PE ratio of Essilor Luxottica (PK)?
The price to earnings ratio of Essilor Luxottica (PK) is 45.68
What is the cash to sales ratio of Essilor Luxottica (PK)?
The cash to sales ratio of Essilor Luxottica (PK) is 4.12
What is the reporting currency for Essilor Luxottica (PK)?
Essilor Luxottica (PK) reports financial results in EUR
What is the latest annual turnover for Essilor Luxottica (PK)?
The latest annual turnover of Essilor Luxottica (PK) is EUR 25.4B
What is the latest annual profit for Essilor Luxottica (PK)?
The latest annual profit of Essilor Luxottica (PK) is EUR 2.29B
What is the registered address of Essilor Luxottica (PK)?
The registered address for Essilor Luxottica (PK) is 147 RUE DE PARIS, CHARENTON-LE-PONT, VAL-DE-MARNE, 94220
What is the Essilor Luxottica (PK) website address?
The website address for Essilor Luxottica (PK) is www.essilorluxottica.com
Which industry sector does Essilor Luxottica (PK) operate in?
Essilor Luxottica (PK) operates in the OPHTHALMIC GOODS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGIOQEdgio Inc (CE)
$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
$ 0.00125
(-10.71%)
169.44M

Discussion

View Full Feed
axelvento axelvento 7 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 10 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 11 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 11 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 12 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 13 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 14 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 15 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 16 minutes ago
Probably
AVXL
HokieHead HokieHead 18 minutes ago
Wrong..
TWOH
HokieHead HokieHead 18 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 20 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 22 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 22 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 23 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 23 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 24 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 25 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 27 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL
facts_matter14 facts_matter14 29 minutes ago
Looks like Baggy is worried about Maxine not showing up at CES this week…………….









.
SRMX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 29 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

OK so we should see the test start this quarter then?
AVXL
Canna_Business Canna_Business 29 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
mrfence mrfence 29 minutes ago
Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
GME
Canna_Business Canna_Business 29 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX

Your Recent History

Delayed Upgrade Clock